172
Views
12
CrossRef citations to date
0
Altmetric
Original Articles

The pharmacokinetics and conversion of the lactone to the carboxylate forms of ginkgolide B in rat plasma

, , , , , , & show all
Pages 337-343 | Received 03 Sep 2012, Accepted 06 Jan 2013, Published online: 19 Feb 2013
 

Abstract

Ginkgolide B consists of three lactone groups, which may undergo hydrolysis, and lead to the rings opening in aqueous solution with different pHs. From mechanisms of pharmacological activity in vivo, the lactone appears to be the active form of the drug. Pharmacokinetics of lactone form (GB-lac) and the total of the lactone and carboxylate form (GB-tot) of ginkgolide B were investigated after intravenous administration of a dose of 4 mg/kg ginkgolide B. The rate of lactone hydrolysis was also studied in plasma in vitro. After intravenous administration, ginkgolide B in the original form was converted to its carboxylate form under simulated physiological conditions. The AUC0 − ∞ of GB-lac constituted 63.5 ± 17.4% of the AUC0 − ∞ of GB-tot. The ratio of average cumulation of excretion of lactone to carboxylate reached approximately 1 to 1 in urine. From the equilibrium of lactone hydrolysis in rat plasma in vitro, the k obs was − 0.0176 min− 1 and t 1/2 was 39.38 min. In conclusion, the equilibrium existed between lactone of ginkgolide B and its carboxylate form in vivo at physiological pH, which suggested that more attention should be focused on the original and the ionization forms of ginkgolide B and the conversion of the lactone into carboxylate in vivo.

Acknowledgements

This study was financially supported by National Natural Science Foundation of China (No. 81001592), the Key Project of Chinese Ministry of Education (No. 210101), the Key Project of Anhui University Provincial Natural Science Research Foundation (Nos. KJ2010A210, KJ2012A186) and Science and Technology Major Projects of Major New Drug Development of China (No. 2009ZX09103-399).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.